Global Assets Leader, Deloitte Consulting
1700 Market Street
Brett Davis is Deloitte Consulting’s Global Assets Leader where he has responsibilities across a portfolio of high growth asset enabled consulting offerings that are powered by innovative new technologies. In this role, he leads the development of portfolio strategy, investment prioritization, go-to-market and commercial enablement, as well as the establishment of new client engagement models and transfer of intellectual property across priority markets.
He was previously the founder and General Manager of ConvergeHEALTH, a business unit focused on supporting the information based transformation of healthcare and life sciences that he founded and launched in 2014. In this role he was responsible for managing Deloitte’s $200M+ investment in new digital engagement and advanced analytics platforms to support the industry’s shift to value based, personalized healthcare. Today, ConvergeHEALTH platforms are live in 23 countries supporting millions of patients and leading biopharmaceutical and healthcare clients in their digital transformations.
In addition to his role at Deloitte, Davis serves on the External Advisory Board of the University of Pennsylvania’s Department of Medical Ethics and Health Policy. Previously he served as a Board member of the Personalized Medicine Coalition for 6 years, and as an external advisor to the Jefferson School of Population Health and Ben & Catherine Ivy Cancer Foundation.
He has been a keynote speaker at numerous industry conferences including HIMSS, AMIA, DIA, ASCO, the National Chamber of Commerce Health Summit, Personalized Medicine World Conference, Harvard Partners Personalized Medicine Conference, and the Annual National Quality Colloquium. Brett has published numerous white papers on the transformative impact of health information technology, and been quoted in publications such as the London Times, InformationWeek, Advanced Clinical Trials, Computer World, Health Data Management, and Bio-IT World.
Prior to joining Deloitte, Davis held leadership roles in life sciences and healthcare at Oracle and IBM.
ConvergeHEALTH by Deloitte Waives Licensing Fees for MyPath for Clinical for COVID and COVID-Impacted Trials
Meet our Products & Solutions leaders